CETP inhibitor

This page covers all CETP inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CETP (cholesterol ester transfer protein), cholesterol ester transfer protein (CETP), CETP (Cholesteryl ester transfer protein).

Targets

CETP (cholesterol ester transfer protein) · cholesterol ester transfer protein (CETP) · CETP (Cholesteryl ester transfer protein)

Phase 3 pipeline (3)

• Monotherapy obicetrapib · NewAmsterdam Pharma · Cardiovascular
  Obicetrapib inhibits CETP (cholesterol ester transfer protein) to increase HDL cholesterol and reduce LDL cholesterol levels.
• Placebo anacetrapib · University of Oxford · Cardiovascular
  Anacetrapib is a cholesterol ester transfer protein (CETP) inhibitor, which increases HDL cholesterol and reduces LDL cholesterol.
• Dalcetrapib (RO4607381) · Hoffmann-La Roche · Cardiovascular
  Dalcetrapib inhibits cholesteryl ester transfer protein (CETP) to increase HDL cholesterol and reduce LDL cholesterol levels.